Alloantigen presenting function of normal human CD34+ hematopoietic cells

Blood

Volumn 88, Issue 7, 1996, Pages 2619-2625

  Rondelli, Damiano ^b   Andrews, Robert G ^b   Hansen, John A ^b   Ryncarz, Rita ^b   Faerber, Marc A ^b   Anasetti, Claudio ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD34 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW SUPPRESSION; CELL GROWTH; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0029819425     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2619.bloodjournal8872619     Document Type: Article

References (22)

1. Uchida N, Fleming WH, Alpern EJ, Weissman IL: Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 5:177, 1993
2. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
3. Andrews RG, Singer JW, Bernstein ID: Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
4. Brandt J, Srour EF, van Besien K, Briddel RA, Hoffman R: Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 86:932, 1990
5. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988
6. lo Lin-Scal + hematopoietic stem cells. Blood 83:3758, 1994
7. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
8. Andrews RG, Bryant EM, Bartelmez SH, Muirhead DY, Knitter GH, Bensinger W, Strong DM, Bernstein ID: CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 80:1693, 1992
9. Berenson RJ, Bensinger WI, Hill RS, Andrew RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED: Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991
10. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81:2579, 1993
11. Beatty PG, Ledbetter JA, Martin PJ, Price TH, Hansen JA: Definition of a common leukocyte cell-surface antigen (Gp95-150) associated with diverse cell-mediated immune functions. J Immunol 131:2913, 1983
12. Tan P, Anasetti C, Martin PJ, Hansen JA: Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor. J Immunol 145:485, 1990
13. Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614, 1981
14. Gunji Y, Nakamura M, Hagiwara T, Hayakawa K, Matsushita H, Osawa H, Nagayoshi K, Nakauchi H, Yanagisawa M, Miura Y, Suda T: Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells. Blood 80:429, 1992
15. Krensky AM, Mentzer SJ, Clayberger C, Anderson DC, Schmalstieg FC, Burakoff SJ, Springer TA: Heritable lymphocyte function-associated antigen-1 deficiency: Abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1. J Immunol 135:3102, 1985
16. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261, 1994
17. Martin PJ, Hansen JA, Storb R, Thomas ED: Human marrow transplantation: An immunological perspective. Adv Immunol 40:379, 1987
18. Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y: Enhancement by methyl myleren of donor type chimerism in murine recipient of bone marrow allografts. Blood 73:2025, 1989
19. Baum CM, Uchida N, Peault B, Weissman IL: Isolation and characterization of hematopoietic progenitor and stem cells, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 53
20. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Iacucci R, Zei T, Martelli MP, Gambelunghe C, Rosetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF: Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 1994
21. Liu Y, Janeway CA Jr: Monoclonal antibodies against the T cell receptor/CD3 complex induce cell death of Th1 clones in the absence of accessory cells. Adv Exp Med Biol 292:105, 1991
22. Wilson C, Kay MA: Immunomodulation to enhance gene therapy. Nature Med 1:887, 1995